DXB 5.62% 42.0¢ dimerix limited

Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-6

  1. 47 Posts.
    lightbulb Created with Sketch. 11
    Non of the above. The drug worked only in the sickest patient in the study, and those patients performed 16% better than the PBO arm
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.